Envas IV 1.25mg Injection Uses and Side Effects

Medicine Name Envas IV 1.25mg Injection
Manufactured By Cadila Pharmaceuticals Ltd
Medicine Category Ace Inhibitors Plain
Salt Composition Enalaprilat (1.25 mg)

Envas IV 1.25mg Injection Side Effects

Decreased blood pressure,Cough,Increased potassium level in blood,Fatigue,Weakness,Dizziness,Renal impairment

Envas IV 1.25mg Injection Uses

Envas IV 1.25mg Injection belongs to a group of medicines known as angiotensin converting enzyme (ACE) inhibitors. It is widely used to treat high blood pressure and heart failure and may be prescribed after a heart attack. It also lowers the chances of having a heart attack or stroke.Envas IV 1.25mg Injection is given as an injection into a vein under the supervision of a doctor. This medicine should be taken at the same time each day to get the most benefit. It is important to continue taking it regularly even if you feel well or even if your blood pressure is controlled. Most people with high blood pressure do not feel ill, but if you stop taking this medicine, your condition could get worse. This is a widely used medicine and is considered safe for long-term use. Making some changes in your lifestyle will also help lower your blood pressure. These may include regular exercise, losing weight, smoking cessation, reducing alcohol intake, and reducing the amount of salt in your diet as advised by your doctor. The most common side effects of this medicine include cough, fatigue, weakness, low blood pressure and increased potassium level. Most of these are temporary and resolve with time. Talk to your doctor if any of the side effects bother you or do not go away.Before taking this medicine, let your doctor know if you have any kidney or liver problems. Pregnant or breastfeeding mothers should also consult their doctor before taking it. Your doctor may check your kidney function, blood pressure and potassium levels in your blood at regular intervals while you are taking this medicine.

Leave a Comment

Your email address will not be published. Required fields are marked *